Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The T-box transcription factor brachyury behaves as a tumor suppressor in gliomas.
Pinto F, Costa ÂM, Santos GC, Matsushita MM, Costa S, Silva VA, Miranda-Gonçalves V, Lopes CM, Clara CA, Becker AP, Neder L, Hajj GN, da Cunha IW, Jones C, Andrade RP, Reis RM. Pinto F, et al. Among authors: matsushita mm. J Pathol. 2020 May;251(1):87-99. doi: 10.1002/path.5419. Epub 2020 Apr 4. J Pathol. 2020. PMID: 32154590
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J. Batista R, et al. Among authors: matsushita mm. Int J Cancer. 2016 Jul 15;139(2):414-23. doi: 10.1002/ijc.30057. Epub 2016 Mar 24. Int J Cancer. 2016. PMID: 26914704
Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP, Fregnani JH, Reis RM, Taveira LN, Scapulatempo-Neto C, Matsushita M, Silva SRM, Oliveira CZ, Longatto-Filho A, Eklund C, Paloheimo L, Mauad E, Suovaniemi O, Syrjänen K. Guimarães DP, et al. Anticancer Res. 2019 Jan;39(1):261-269. doi: 10.21873/anticanres.13106. Anticancer Res. 2019. PMID: 30591467
Lack of KBTBD4 Mutations in Molecularly Classified Brazilian Medulloblastomas.
Leal LF, Cavagna RO, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro F, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Leal LF, et al. J Neuropathol Exp Neurol. 2019 Sep 1;78(9):788-790. doi: 10.1093/jnen/nlz066. J Neuropathol Exp Neurol. 2019. PMID: 31403685
Mutation profiling of cancer drivers in Brazilian colorectal cancer.
Dos Santos W, Sobanski T, de Carvalho AC, Evangelista AF, Matsushita M, Berardinelli GN, de Oliveira MA, Reis RM, Guimarães DP. Dos Santos W, et al. Sci Rep. 2019 Sep 23;9(1):13687. doi: 10.1038/s41598-019-49611-1. Sci Rep. 2019. PMID: 31548566 Free PMC article.
Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup.
da Silva LS, Mançano BM, de Paula FE, Dos Reis MB, de Almeida GC, Matsushita M, Junior CA, Evangelista AF, Saggioro F, Serafini LN, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, de Lima MA, Taylor MD, Leal LF, Reis RM. da Silva LS, et al. J Mol Diagn. 2020 Jul;22(7):957-966. doi: 10.1016/j.jmoldx.2020.04.207. Epub 2020 May 4. J Mol Diagn. 2020. PMID: 32380172 Free article.
The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer Hospital.
Guimarães DP, Mantuan LA, de Oliveira MA, Junior RL, Costa AMD, Rossi S, Fava G, Taveira LN, Giardina KM, Talarico T, Costa M, Scapulatempo-Neto C, Matsushita MM, Véo CA, Fregnani JHT, Reis RM, Hawk ET, Mauad EC. Guimarães DP, et al. Among authors: matsushita mm. Cancer Prev Res (Phila). 2021 Feb;14(2):241-252. doi: 10.1158/1940-6207.CAPR-20-0179. Epub 2020 Sep 30. Cancer Prev Res (Phila). 2021. PMID: 32998941
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS, Grasel RS, Campacci N, de Paula AE, Galvão HCR, Torrezan GT, Sabato CS, Fernandes GC, Souza CP, Michelli RD, Andrade CE, Barros BDF, Matsushita MM, Revil T, Ragoussis J, Couch FJ, Hart SN, Reis RM, Melendez ME, Tonin PN, Carraro DM, Palmero EI. Felicio PS, et al. Among authors: matsushita mm. Hum Mutat. 2021 Mar;42(3):290-299. doi: 10.1002/humu.24158. Epub 2020 Dec 28. Hum Mutat. 2021. PMID: 33326660 Free PMC article.
59 results